Skip to main content
NeuroPace Inc logo

NeuroPace Inc — Investor Relations & Filings

Ticker · NPCE ISIN · US6412881053 US Manufacturing
Filings indexed 314 across all filing types
Latest filing 2025-12-01 Director's Dealing
Country US United States of America
Listing US NPCE

About NeuroPace Inc

https://www.neuropace.com/

NeuroPace Inc. is a commercial-stage medical device company focused on the treatment of neurological disorders. The company designs, develops, and markets implantable devices that utilize responsive neurostimulation. Its flagship product, the RNS® System, is the only FDA-approved brain-responsive neurostimulation system for adults with drug-resistant focal epilepsy. The RNS System continuously monitors brain activity, detects patient-specific abnormal electrical patterns, and delivers personalized electrical stimulation in real-time to prevent seizures at their source. In addition to providing therapeutic stimulation, the device also records and provides physicians with long-term electroencephalographic (EEG) data to help optimize patient care and treatment plans.

Recent filings

Filing Released Lang Actions
Director's Dealing 2025
Director's Dealing
2025-12-01 English
Director's Dealing 2025
Director's Dealing
2025-12-01 English
Director's Dealing 2025
Director's Dealing
2025-11-24 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-07 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-04 English
8-K
Regulatory Filings
2025-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.